Public Law 52
Summary
The law stops state employee health plans, accident‑and‑sickness policies, and health‑maintenance organizations from requiring a patient to fail another medication before covering a drug for advanced, metastatic cancer that is FDA‑approved, evidence‑based, and follows best practice. It applies to plans and contracts created or renewed after June 30 2026. The change is meant to give patients quicker access to needed cancer therapies.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Topics
Track this bill
Get real-time alerts when HB 1114 changes status, plus AI-powered summaries and stage predictions.
Sign up free